Safety and Tolerability Study of QLS-101 in Adolescents With Sturge-Weber Syndrome (SWS)-Related Glaucoma Due to Elevated Episcleral Venous Pressure (EVP)

NCT05495269 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

2

Enrollment

INDUSTRY

Sponsor class

Conditions

Sturge-Weber Syndrome
Glaucoma
Ocular Hypertension

Interventions

DRUG: QLS-101 ophthalmic solution, 2.0 %

Sponsor

Qlaris Bio, Inc.